218 related articles for article (PubMed ID: 18327394)
1. Platelet GPIb complex as a target for anti-thrombotic drug development.
Clemetson KJ; Clemetson JM
Thromb Haemost; 2008 Mar; 99(3):473-9. PubMed ID: 18327394
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
3. Platelets and primary haemostasis.
Clemetson KJ
Thromb Res; 2012 Mar; 129(3):220-4. PubMed ID: 22178577
[TBL] [Abstract][Full Text] [Related]
4. Decreased thrombotic tendency in mouse models of the Bernard-Soulier syndrome.
Strassel C; Nonne C; Eckly A; David T; Leon C; Freund M; Cazenave JP; Gachet C; Lanza F
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):241-7. PubMed ID: 17095718
[TBL] [Abstract][Full Text] [Related]
5. Snake venom C-type lectins interacting with platelet receptors. Structure-function relationships and effects on haemostasis.
Lu Q; Navdaev A; Clemetson JM; Clemetson KJ
Toxicon; 2005 Jun; 45(8):1089-98. PubMed ID: 15876445
[TBL] [Abstract][Full Text] [Related]
6. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?
Xu G; Ulrichts H; Vauterin S; De Meyer SF; Deckmyn H; Teng M; Niu L
Toxicon; 2005 Apr; 45(5):561-70. PubMed ID: 15777951
[TBL] [Abstract][Full Text] [Related]
7. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of von Willebrand factor-GPIb/IX/V interactions as a strategy to prevent arterial thrombosis.
Bonnefoy A; Vermylen J; Hoylaerts MF
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):257-69. PubMed ID: 15030285
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet glycoprotein Ib and its antithrombotic potential.
Vanhoorelbeke K; Ulrichts H; Van de Walle G; Fontayne A; Deckmyn H
Curr Pharm Des; 2007; 13(26):2684-97. PubMed ID: 17897012
[TBL] [Abstract][Full Text] [Related]
10. Platelet glycoprotein Ib-IX as a regulator of systemic inflammation.
Corken A; Russell S; Dent J; Post SR; Ware J
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):996-1001. PubMed ID: 24504734
[TBL] [Abstract][Full Text] [Related]
11. [Involvement of platelet collagen receptors in primary hemostasis].
Kralisz U; Stasiak M
Postepy Biochem; 2007; 53(4):344-55. PubMed ID: 19024899
[TBL] [Abstract][Full Text] [Related]
12. Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury.
Pfeiffer S; Zorn GL; Zhang JP; Giorgio TD; Robson SC; Azimzadeh AM; Pierson RN
Transplantation; 2003 Apr; 75(7):953-9. PubMed ID: 12698079
[TBL] [Abstract][Full Text] [Related]
13. LIM kinase-1 selectively promotes glycoprotein Ib-IX-mediated TXA2 synthesis, platelet activation, and thrombosis.
Estevez B; Stojanovic-Terpo A; Delaney MK; O'Brien KA; Berndt MC; Ruan C; Du X
Blood; 2013 May; 121(22):4586-94. PubMed ID: 23620575
[TBL] [Abstract][Full Text] [Related]
14. Role for platelet glycoprotein Ib-IX and effects of its inhibition in endotoxemia-induced thrombosis, thrombocytopenia, and mortality.
Yin H; Stojanovic-Terpo A; Xu W; Corken A; Zakharov A; Qian F; Pavlovic S; Krbanjevic A; Lyubimov AV; Wang ZJ; Ware J; Du X
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2529-37. PubMed ID: 24051142
[TBL] [Abstract][Full Text] [Related]
15. Thrombin mutant W215A/E217A acts as a platelet GPIb antagonist.
Berny MA; White TC; Tucker EI; Bush-Pelc LA; Di Cera E; Gruber A; McCarty OJ
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):329-34. PubMed ID: 17962622
[TBL] [Abstract][Full Text] [Related]
16. Aurintricarboxylic acid reduces platelet deposition in stenosed and endothelially injured rabbit carotid arteries more effectively than other antiplatelet interventions.
Golino P; Ragni M; Cirillo P; Pascucci I; Ezekowitz MD; Pawashe A; Scognamiglio A; Pace L; Guarino A; Chiariello M
Thromb Haemost; 1995 Sep; 74(3):974-9. PubMed ID: 8571332
[TBL] [Abstract][Full Text] [Related]
17. Simulation of platelet adhesion and aggregation regulated by fibrinogen and von Willebrand factor.
Mori D; Yano K; Tsubota K; Ishikawa T; Wada S; Yamaguchi T
Thromb Haemost; 2008 Jan; 99(1):108-15. PubMed ID: 18217141
[TBL] [Abstract][Full Text] [Related]
18. Development of antibodies that interfere with the collagen-VWF-GPIb axis as new antithrombotics.
Deckmyn H; Cauwenberghs N; Wu D; Depraetere H; Vanhoorelbeke K
Verh K Acad Geneeskd Belg; 2005; 67(1):55-65. PubMed ID: 15828307
[TBL] [Abstract][Full Text] [Related]
19. Platelet interactions in thrombosis.
Andrews RK; Gardiner EE; Shen Y; Berndt MC
IUBMB Life; 2004 Jan; 56(1):13-8. PubMed ID: 14992375
[TBL] [Abstract][Full Text] [Related]
20. The 14-3-3zeta-GPIb-IX-V complex as an antiplatelet target.
Andrews RK; Du X; Berndt MC
Drug News Perspect; 2007 Jun; 20(5):285-92. PubMed ID: 17878956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
